Source: Annual Congress 2012 - New aspects of lung cancer biology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
K. Antoniou, I. Lasithiotaki, S. Derdas, E. Sarchianaki, A. Psaraki, D. Spandidos, E. Stathopoulos, N. Siafakas, G. Sourvinos (Heraklion, Greece). Increased incidence of Merkel cell polyoma virus in non-small-cell lung cancer. Eur Respir J 2012; 40: Suppl. 56, 1227

Member's Comments

No comment yet.

Related content which might interest you: Overexpression of miR-21 in non-small cell lung cancer, positive for Merkel cell polyoma virus (ΜCPyV) Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients Source: Eur Respir J 2006; 28: Suppl. 50, 87s Year: 2006 Update on nonsmall cell lung cancer Source: Eur Respir Rev 2010 19: 173-185 Year: 2010 The role of human papilloma virus in the development of lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 Management of EGFR mutated nonsmall cell lung carcinoma patients Source: Eur Respir J 2015; 45: 1132-1141 Year: 2015 Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006 HER-2/neu oncoprotein expression in nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002 Metastatic disease in non-small cell lung cancer: is it all the same? Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017 Radio(chemo)therapy in locally advanced nonsmall cell lung cancer Source: Eur Respir Rev 2015; 25: 65-70 Year: 2016 Procalitonin: A prognosis factor in lung cancer and a marker for small-cell lung cancer Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 361s Year: 2003 Ki-67 in non-small cell lung cancer Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 Ras peptide-specific vaccination in patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2006 - Lung cancer treatment Year: 2006 Survivin expression in non-small cell lung cancer Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 Breast metastasis in association with non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 538s Year: 2005 Soluble non-invasive markers in non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 459s Year: 2005 Targeted therapy in non-small cell lung cancer Source: Breathe 2012; 8: 206-215 Year: 2012 How to treat a T1-T3N0 non-small cell lung cancer (NSCLC) with isolated brain metastasis Source: International Congress 2015 – How to treat brain metastases Year: 2015 Nonsmall cell lung cancer Source: Annual Congress 2012 - Maurizio Vignola Award for Innovation in Pneumology Ceremony (supported by Chiesi Foundation) followed by Clinical Year in Review I Year: 2012